192 related articles for article (PubMed ID: 36933012)
1. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Bogumil H; Sill M; Schrimpf D; Ismer B; Blume C; Rahmanzade R; Hinz F; Cherkezov A; Banan R; Friedel D; Reuss DE; Selt F; Ecker J; Milde T; Pajtler KW; Schittenhelm J; Hench J; Frank S; Boldt HB; Kristensen BW; Scheie D; Melchior LC; Olesen V; Sehested A; Boué DR; Abdullaev Z; Satgunaseelan L; Kurth I; Seidlitz A; White CL; Ng HK; Shi ZF; Haberler C; Deckert M; Timmer M; Goldbrunner R; Tauziède-Espariat A; Varlet P; Brandner S; Alexandrescu S; Snuderl M; Aldape K; Korshunov A; Witt O; Herold-Mende C; Unterberg A; Wick W; Pfister SM; von Deimling A; Jones DTW; Sahm F; Sievers P
Acta Neuropathol; 2023 May; 145(5):667-680. PubMed ID: 36933012
[TBL] [Abstract][Full Text] [Related]
2. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
[TBL] [Abstract][Full Text] [Related]
3. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
[TBL] [Abstract][Full Text] [Related]
4. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
Hou Y; Pinheiro J; Sahm F; Reuss DE; Schrimpf D; Stichel D; Casalini B; Koelsche C; Sievers P; Wefers AK; Reinhardt A; Ebrahimi A; Fernández-Klett F; Pusch S; Meier J; Schweizer L; Paulus W; Prinz M; Hartmann C; Plate KH; Reifenberger G; Pietsch T; Varlet P; Pagès M; Schüller U; Scheie D; de Stricker K; Frank S; Hench J; Pollo B; Brandner S; Unterberg A; Pfister SM; Jones DTW; Korshunov A; Wick W; Capper D; Blümcke I; von Deimling A; Bertero L
Acta Neuropathol; 2019 May; 137(5):837-846. PubMed ID: 30759284
[TBL] [Abstract][Full Text] [Related]
5. A case of recurrent epilepsy-associated rosette-forming glioneuronal tumor with anaplastic transformation in the absence of therapy.
Halfpenny A; Ferris SP; Grafe M; Woltjer R; Selden N; Nazemi K; Perry A; Solomon DA; Gultekin SH; Moore S; Olson S; Lawce H; Lucas L; Corless CL; Wood MD
Neuropathology; 2019 Oct; 39(5):389-393. PubMed ID: 31435988
[TBL] [Abstract][Full Text] [Related]
6. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
[TBL] [Abstract][Full Text] [Related]
7. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity.
Siegfried A; Rousseau A; Maurage CA; Pericart S; Nicaise Y; Escudie F; Grand D; Delrieu A; Gomez-Brouchet A; Le Guellec S; Franchet C; Boetto S; Vinchon M; Sol JC; Roux FE; Rigau V; Bertozzi AI; Jones DTW; Figarella-Branger D; Uro-Coste E
Brain Pathol; 2019 Jan; 29(1):53-62. PubMed ID: 29679497
[TBL] [Abstract][Full Text] [Related]
8. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.
Murdock T; Orr B; Allen S; Ibrahim J; Sharma R; Ronnett BM; Rodriguez FJ
Am J Surg Pathol; 2018 Nov; 42(11):1429-1444. PubMed ID: 30074494
[TBL] [Abstract][Full Text] [Related]
9. A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions.
Tauziède-Espariat A; Chotard G; le Loarer F; Baud J; Azmani R; Dangouloff-Ros V; Boddaert N; Icher-de-Bouyn C; Gimbert E; Hasty L; Métais A; Chrétien F; Varlet P;
Acta Neuropathol Commun; 2022 Feb; 10(1):15. PubMed ID: 35115049
[TBL] [Abstract][Full Text] [Related]
10. Low-grade epilepsy-associated neuroepithelial tumours with a prominent oligodendroglioma-like component: The diagnostic challenges.
Métais A; Appay R; Pagès M; Gallardo C; Silva K; Siegfried A; Perbet R; Maurage CA; Scavarda D; Fina F; Uro-Coste E; Riffaud L; Colin C; Figarella-Branger D;
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12769. PubMed ID: 34551121
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
[TBL] [Abstract][Full Text] [Related]
12. Molecular and clinicopathologic features of gliomas harboring NTRK fusions.
Torre M; Vasudevaraja V; Serrano J; DeLorenzo M; Malinowski S; Blandin AF; Pages M; Ligon AH; Dong F; Meredith DM; Nasrallah MP; Horbinski C; Dahiya S; Ligon KL; Santi M; Ramkissoon SH; Filbin MG; Snuderl M; Alexandrescu S
Acta Neuropathol Commun; 2020 Jul; 8(1):107. PubMed ID: 32665022
[TBL] [Abstract][Full Text] [Related]
13. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
[TBL] [Abstract][Full Text] [Related]
14. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features.
Deng MY; Sill M; Chiang J; Schittenhelm J; Ebinger M; Schuhmann MU; Monoranu CM; Milde T; Wittmann A; Hartmann C; Sommer C; Paulus W; Gärtner J; Brück W; Rüdiger T; Leipold A; Jaunmuktane Z; Brandner S; Giangaspero F; Nozza P; Mora J; Morales la Madrid A; Cruz Martinez O; Hansford JR; Pietsch T; Tietze A; Hernáiz-Driever P; Stoler I; Capper D; Korshunov A; Ellison DW; von Deimling A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2018 Aug; 136(2):239-253. PubMed ID: 29766299
[TBL] [Abstract][Full Text] [Related]
15. Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor.
Alvarez-Breckenridge C; Miller JJ; Nayyar N; Gill CM; Kaneb A; D'Andrea M; Le LP; Lee J; Cheng J; Zheng Z; Butler WE; Multani P; Chow Maneval E; Ha Paek S; Toyota BD; Dias-Santagata D; Santagata S; Romero J; Shaw AT; Farago AF; Yip S; Cahill DP; Batchelor TT; Iafrate AJ; Brastianos PK
NPJ Precis Oncol; 2017; 1(1):5. PubMed ID: 29872694
[TBL] [Abstract][Full Text] [Related]
16. High-grade glioneuronal tumor with an ARHGEF2-NTRK1 fusion gene.
Kurozumi K; Nakano Y; Ishida J; Tanaka T; Doi M; Hirato J; Yoshida A; Washio K; Shimada A; Kohno T; Ichimura K; Yanai H; Date I
Brain Tumor Pathol; 2019 Jul; 36(3):121-128. PubMed ID: 31011918
[TBL] [Abstract][Full Text] [Related]
17. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion.
Pages M; Lacroix L; Tauziede-Espariat A; Castel D; Daudigeos-Dubus E; Ridola V; Gilles S; Fina F; Andreiuolo F; Polivka M; Lechapt-Zalcman E; Puget S; Boddaert N; Liu XQ; Bridge JA; Grill J; Chretien F; Varlet P
Acta Neuropathol Commun; 2015 Dec; 3():85. PubMed ID: 26671581
[TBL] [Abstract][Full Text] [Related]
18. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
Bale TA; Rosenblum MK
Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
[TBL] [Abstract][Full Text] [Related]
19. ATRX protein loss and deregulation of PI3K/AKT pathway is frequent in pilocytic astrocytoma with anaplastic features.
Olar A; Tran D; Mehta VP; Reinhardt A; Manekia JH; Garnovskaya M; Ellezam B; Luthra R; Sulman EP; Mohila CA; Campbell GA; Powell SZ; Fuller GN; Aldape KD; Adesina AM
Clin Neuropathol; 2019; 38(2):59-73. PubMed ID: 30499772
[TBL] [Abstract][Full Text] [Related]
20. BCOR::CREBBP fusion in malignant neuroepithelial tumor of CNS expands the spectrum of methylation class CNS tumor with BCOR/BCOR(L1)-fusion.
Ebrahimi A; Waha A; Schittenhelm J; Gohla G; Schuhmann MU; Pietsch T
Acta Neuropathol Commun; 2024 Apr; 12(1):60. PubMed ID: 38637838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
